France· FR:67764293
RIVASTIGMINE SANDOZ 9,5 mg/24 h, dispositif transdermique
A medicinal product containing rivastigmine base, registered in France by SANDOZ.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- RIVASTIGMINE BASE
- Manufacturer
- SANDOZ
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip13340092781929230 sachet(s) papier polyéthylène téréphtalate aluminium polyacrylonitrile de 1 dispositif(s)
- cip13340093021664430 sachet(s) papier polyéthylène téréphtalate aluminium polyamide de 1 dispositif(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rivastigmine base in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesRivastigmineMylan Pharmaceuticals Inc.
- SpainRIVASTIGMINA RATIOPHARM 9,5 MG/24H PARCHES TRASDERMICOS EFGTeva Pharma S.L.U.
- CzechiaEXELONNovartis Europharm Limited, Dublin
- United KingdomAlmuriva 13.3mg/24hours transdermal patchesSandoz Ltd
- FinlandAcolinAvansor Pharma Oy
- NetherlandsExelon 1,5 mg, harde capsulesNovartis Europharm Limited
- BelgiumAldemyl 4.6 mg/24 hViatris GX
- SwedenExelon 1,5 mg Kapsel, hårdNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Nimgista, Rivagelan
- Belgium · Rivastigmin Sandoz, Rivastigmine Viatris
- Bulgaria · Ридаксин
- Germany · Demelora, Rivastigmin
- Denmark · Rigmin, Rivastigmin Orion
- Spain · Alzerta, Alzerta Dos Por Semana
- Finland · Rivastigmin Orion, Rivastigmine Sandoz
- United Kingdom (Northern Ireland) · Almuriva, Alzest
- Greece · Alapril, Balaxon
- Iceland · Exelon, Nimvastid
- Italy · Demelora, Rivastigmina Aurobindo
- Liechtenstein · Exelon, Rivastigmine 1 A Pharma
- Malta · Rivastigmine Aurobindo
- Netherlands · Ristidic, Rivastgimine Neuraxpharm
- Norway · Exelon, Nimvastid
- Poland · Atmina, Evertas
- Portugal · Nervopan, Rivastigmina Alter
- Romania · Evertas, Ridaxin
- Sweden · Rigmin, Rivastigmin Orion
- Slovenia · Rivastigmin Teva, Rivastigmin Teva B.V.
- Slovakia · Ristidic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ab5405c9-8ef5-4657-8bfc-33b81c76ff2f GET /v1/drugs/ab5405c9-8ef5-4657-8bfc-33b81c76ff2f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67764293",
"date_amm": "2014-06-24",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "RIVASTIGMINE BASE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "dispositif",
"voies_administration": "transdermique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about rivastigmine base.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.